Financial strain, work conflicts, and anxiety about doctor visits are the primary reasons millions of eligible women skip breast and cervical cancer screening, according to new research that challenges the assumption that better education alone will boost screening rates. A comprehensive analysis of over 160,000 U.S. adults found that at least one barrier prevented 37% of women eligible for breast cancer screening and 50% of those eligible for cervical cancer screening from getting tested .

What's Actually Stopping Women From Getting Screened?

Researchers from the All of Us Research Program examined screening data collected between 2017 and 2023 to understand why eligible adults weren't following recommended cancer screening guidelines. The findings paint a clear picture of systemic obstacles that go far beyond simple awareness gaps .

The most frequently reported barriers fell into three distinct categories:

• Financial Obstacles: Out-of-pocket costs emerged as a major deterrent, with cost concerns linked to lower screening odds for breast, cervical, and colorectal cancer screening
• Logistical Challenges: Transportation difficulties, distance to screening facilities, and physical barriers to accessing care reduced adherence across multiple cancer types
• Life Circumstances: Difficulty getting time off work and competing caregiving responsibilities prevented eligible adults from prioritizing screening appointments

Beyond these primary barriers, nervousness about seeing a clinician also emerged as a significant factor. The research revealed that these obstacles don't operate in isolation; instead, they compound one another. When people faced three or more barriers simultaneously, screening rates dropped dramatically. Among those with multiple barriers, breast cancer screening adherence fell to 44% compared to the overall rate of 52%, while cervical cancer screening plummeted to 24% from a baseline of 29% .

How Do Multiple Barriers Affect Screening Decisions?

The study's most striking finding was the cumulative effect of barriers. Participants reporting three or more obstacles were significantly less likely to complete screening across all five cancer types studied. Specifically, those facing multiple barriers were 29% less likely to meet breast cancer screening recommendations and 20% less likely to complete cervical cancer screening compared to those reporting no barriers .

This pattern held true even for cancers with well-established screening protocols. The data suggests that a woman facing financial hardship, transportation challenges, and work scheduling conflicts is far less likely to get screened than someone facing just one of these obstacles. The compounding effect means that interventions addressing only one barrier are unlikely to meaningfully improve screening rates.

Steps to Improve Cancer Screening Access

• Reduce Financial Burden: Expand insurance coverage for screening tests and eliminate or reduce out-of-pocket costs for eligible individuals, making screening truly accessible regardless of income level
• Improve Logistical Support: Increase mobile screening units, offer telehealth consultations where appropriate, and provide transportation assistance to help patients overcome distance and accessibility barriers
• Increase Work Flexibility: Encourage employers to offer paid time off specifically for preventive health screenings and partner with occupational health programs to integrate screening into workplace wellness initiatives
• Address Emotional Barriers: Develop patient education programs that normalize screening anxiety and provide coping strategies, while training healthcare providers in trauma-informed approaches to reduce nervousness about clinical visits

The research authors emphasized that solving the screening gap requires coordinated, multi-level approaches rather than isolated fixes. "Improving cancer screening may require coordinated approaches that address affordability, transportation, work flexibility, and patient concerns at the same time," the study noted .

Why Personalized Screening Strategies Matter

Beyond removing barriers to access, experts are also advocating for more personalized screening approaches. For breast cancer specifically, many women are now learning they have dense breast tissue, a risk factor that affects approximately 40% of women. However, this information often leaves patients confused about next steps, since current guidelines offer limited guidance for average-risk women with dense breasts .

"Dense breast notification should prompt a conversation. But if a formal risk assessment has not been done, there are no clear, consistent recommendations for what should happen next," explained Elena Elkin, PhD, Professor of Health Policy and Management at Columbia University Irving Medical Center.

Elena Elkin, PhD, Professor of Health Policy and Management, Columbia University Irving Medical Center

The challenge is that implementing personalized risk assessment in routine primary care requires time and resources that many clinicians don't have. Electronic health records often lack the tools to automatically extract and standardize the data needed for accurate risk assessment, and many existing risk models were developed primarily in white populations, raising concerns about accuracy in other racial and ethnic groups .

The Global Picture: HPV Screening and Cervical Cancer Prevention

While U.S. screening rates remain suboptimal, the global burden of cervical cancer and other HPV-related cancers is far more severe. Human papillomavirus (HPV) causes an estimated 830,000 new cancer cases and more than 400,000 deaths worldwide each year, yet the majority of these cancers are either 90 to 100% preventable through vaccination or detectable at an early stage through screening .

The World Health Organization has set an ambitious goal to eradicate cervical cancer by 2030, but achieving this requires more than just scientific tools. Self-collected HPV testing, approved by the FDA in 2024, has shown remarkable promise. A 2025 meta-analysis found that self-collection with a mail-in option doubled screening rates among people who were not regularly screened, precisely the population at highest risk for cervical cancer .

"Seventy-seven percent of HPV cancers occur in low- and middle-income countries, a disproportion driven directly by limited access to vaccination and screening programs," explained Dr. Barbara Goff, Professor and Chair of the Department of Obstetrics and Gynecology.

Dr. Barbara Goff, Professor and Chair of the Department of Obstetrics and Gynecology

The disparity is stark: in the highest-burden regions, cervical cancer incidence reaches 77 cases per 100,000 people with 52 deaths per 100,000, compared to just 20 cases and 6 deaths per 100,000 in North America . Women account for approximately 736,000 of the 830,000 annual HPV-related cancer cases globally, with nearly 400,000 women dying from these preventable cancers each year .

The bottom line is clear: the science exists to prevent and detect these cancers early. What's missing is the infrastructure, funding, and coordinated effort to make screening and prevention accessible to everyone who needs it. For women in the United States facing financial, logistical, and emotional barriers, and for billions globally with limited access to screening programs, the gap between what's possible and what's actually available remains dangerously wide.